DNA Sequences Encoding CD4+ and CD8+T-Cell Epitopes Are Important for Efficient Protective Immunity Induced by DNA Vaccination with a Trypanosoma cruziGene

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Infection and Immunity

• Publication date

  2001-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.69.9.5477-5486.2001PMID 11500420PMCID PMC98660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epitope affinity for MHC class I determines helper requirement for CTL priming

  2000influential reference
• CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism.

  2000cited by this paper
• Increased Susceptibility of Stat4-Deficient and Enhanced Resistance in Stat6-Deficient Mice to Infection with Trypanosoma cruzi1

  2000cited by this paper
• Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies.

  2000cited by this paper
• Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.

  2000cited by this paper
• DNA-Based Immunization with Trypanosoma cruzi Complement Regulatory Protein Elicits Complement Lytic Antibodies and Confers Protection against Trypanosoma cruzi Infection

  2000cited by this paper
• β-Chemokines Enhance Parasite Uptake and Promote Nitric Oxide-Dependent Microbiostatic Activity in Murine Inflammatory Macrophages Infected with Trypanosoma cruzi

  1999cited by this paper
• Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.

  1999cited by this paper
• Predominance of CD4 Th1 and CD8 Tc1 Cells Revealed by Characterization of the Cellular Immune Response Generated by Immunization with a DNA Vaccine Containing a Trypanosoma cruzi Gene

  1999cited by this paper
• Granulysin: a lethal weapon of cytolytic T cells.

  1999cited by this paper
• Chagas disease etiology: autoimmunity or parasite persistence?

  1999cited by this paper
• beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi.

  1999cited by this paper
• Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization.

  1999cited by this paper
• Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes.

  1999cited by this paper
• Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O.

  1999cited by this paper
• Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.

  1998cited by this paper
• Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.

  1998cited by this paper
• Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL.

  1998cited by this paper
• The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi

  1998cited by this paper
• Defective Nitric Oxide Effector Functions Lead to Extreme Susceptibility of Trypanosoma cruzi-Infected Mice Deficient in Gamma Interferon Receptor or Inducible Nitric Oxide Synthase

  1998cited by this paper
• DNA Immunization with Minigenes: Low Frequency of Memory Cytotoxic T Lymphocytes and Inefficient Antiviral Protection Are Rectified by Ubiquitination

  1998cited by this paper
• Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium.

  1998cited by this paper
• Vaccination with Trypomastigote Surface Antigen 1-Encoding Plasmid DNA Confers Protection against Lethal Trypanosoma cruzi Infection

  1998cited by this paper
• Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.

  1998cited by this paper
• Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.

  1997cited by this paper
• Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.

  1997cited by this paper
• Cell-mediated immunity in experimental Trypanosoma cruzi infection.

  1997cited by this paper
• Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase.

  1997cited by this paper
• Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease.

  1996cited by this paper
• Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease

  1995cited by this paper
• Structural and functional properties of Trypanosoma trans-sialidase.

  1994cited by this paper
• Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome.

  1993cited by this paper
• Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei

  1993cited by this paper
• Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase.

  1993cited by this paper
• Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.

  1993cited by this paper
• Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.

  1992cited by this paper
• Synergism between tumor necrosis factor‐α and interferon‐γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide‐dependent mechanism

  1992cited by this paper
• Only some members of a gene family in Trypanosoma cruzi encode proteins that express both trans‐sialidase and neuraminidase activities.

  1992cited by this paper
• Protective effects of specific antibodies in Trypanosoma cruzi infections.

  1976cited by this paper

• Highly cross-reactive and competent effectors dominate the CD8+ T cell response in Trypanosoma cruzi infection.

  2025cites this paper
• Epitopes in the Glycosylphosphatidylinositol Attachment Signal Peptide of Trypanosoma cruzi Mucin Proteins Generate Robust But Delayed and Nonprotective CD8+ T Cell Responses.

  2023cites this paper
• The high identity of the Trypanosoma cruzi Group‐I of trans‐sialidases points them as promising vaccine immunogens

  2023cites this paper
• Use of Leishmania major parasites expressing a recombinant Trypanosoma cruzi antigen as live vaccines against Chagas disease

  2022cites this paper
• Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection.

  2020cites this paper
• Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice

  2018cites this paper
• Protective host response to Trypanosoma cruzi and its limitations

  2017cites this paper
• Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity

  2016influential citation
• Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells

  2016cites this paper
• Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi

  2016cites this paper
• Antigen Targeting to Dendritic Cells Allows the Identification of a CD4 T-Cell Epitope within an Immunodominant Trypanosoma cruzi Antigen

  2015cites this paper
• An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8+ T cell epitopes

  2015influential citation
• Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.

  2015cites this paper
• CD8+ T Cell-Mediated Immunity during Trypanosoma cruzi Infection: A Path for Vaccine Development?

  2014cites this paper
• Genetic Vaccination against Experimental Infection with Myotropic Parasite Strains of Trypanosoma cruzi

  2014cites this paper
• Immunization with Hexon Modified Adenoviral Vectors Integrated with gp83 Epitope Provides Protection against Trypanosoma cruzi Infection

  2014cites this paper
• Development of Vaccines Using SeV Vectors Against AIDS and Other Infectious Diseases

  2013cites this paper
• Differential immune response in mice immunized with the A, R or C domain from TcSP protein of Trypanosoma cruzi or with the coding DNAs

  2013cites this paper
• Trypanosoma cruzi Infection Memory Phenotype during Persistent Antigen-Specific T Cells Maintain an Effector

  2013cites this paper
• Sendai Virus Vector

  2013cites this paper
• Trans-sialidase-like gene from the bloodstream form of Trypanosoma evansi conserves most of the active site residues and motifs found in Trypanosomal sialidases and trans-sialidases

  2012cites this paper
• Nonimmune Cells Contribute to Crosstalk between Immune Cells and Inflammatory Mediators in the Innate Response to Trypanosoma cruzi Infection

  2011cites this paper
• Generation of novel Chagas vaccines: evolving studies/work in progress

  2011cites this paper
• A DNA Vaccine Encoding for TcSSP4 Induces Protection against Acute and Chronic Infection in Experimental Chagas Disease

  2011cites this paper
• The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.

  2011cites this paper
• In vitro organic matter digestibility and gas production of fish-meal coated with fat

  2011cites this paper
• Protective Host Response to Parasite and Its Limitations

  2010cites this paper
• Immunization with the recombinant surface protein rTcSP2 alone or fused to the CHP or ATPase domain of TcHSP70 induces protection against acute Trypanosoma cruzi infection

  2010cites this paper
• Cross‐presentation of peptides from intracellular pathogens by MHC class I molecules

  2010cites this paper
• Intranasal Vaccinations with the trans-Sialidase Antigen plus CpG Adjuvant Induce Mucosal Immunity Protective against Conjunctival Trypanosoma cruzi Challenges

  2010cites this paper
• T. cruzi parasite-specific humoral immunity versus polyclonal activation

  2010cites this paper
• Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection.

  2010cites this paper
• Swimming against the current: genetic vaccination against Trypanosoma cruzi infection in mice.

  2009cites this paper
• Vacinação com a proteína 2 da superfície de amastigotas contra a infecção experimental pelo Trypanosoma cruzi: eficácia de diferentes estratégias vacinais e mecanismos de imunidade

  2009cites this paper
• Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research.

  2009cites this paper
• Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.

  2009cites this paper
• Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.

  2009cites this paper
• Genetic Immunization Converts the Trypanosoma cruzi B-Cell Mitogen Proline Racemase to an Effective Immunogen

  2009cites this paper
• Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.

  2008cites this paper
• Geração e análise da imunogenicidade de plasmídeos contendo epítopos CD8 sub-dominantes expressos em Trypanosoma cruzi

  2008cites this paper
• Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.

  2008cites this paper
• HLA Class I-T Cell Epitopes from trans-Sialidase Proteins Reveal Functionally Distinct Subsets of CD8+ T Cells in Chronic Chagas Disease

  2008cites this paper
• Novel Protective Antigens Expressed by Trypanosoma cruzi Amastigotes Provide Immunity to Mice Highly Susceptible to Chagas' Disease

  2008cites this paper
• Role of Trypanosoma cruzi Autoreactive T Cells in the Generation of Cardiac Pathology

  2007cites this paper
• Cell-Mediated Cross-Priming CTL and B + Immunity Involving CD 8 Trypanosoma cruzi Mucosal and Systemic Oligodeoxynucleotide Induces Protective with CpG Motif-Containing-Sialidase Recombinant Protein Mixed Trans

  2007cites this paper
• Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection

  2007cites this paper
• DNA Vaccines against Protozoan Parasites: Advances and Challenges

  2007cites this paper
• Trans-Sialidase Recombinant Protein Mixed with CpG Motif-Containing Oligodeoxynucleotide Induces Protective Mucosal and Systemic Trypanosoma cruzi Immunity Involving CD8+ CTL and B Cell-Mediated Cross-Priming1

  2007cites this paper
• Parasite-Induced Chronic Inflammation Is Not Exacerbated by Immunotherapy before or during Trypanosoma cruzi Infection

  2007cites this paper
• Comparative evaluationoftherapeuticDNAvaccines against Trypanosoma cruzi inmice

  2007cites this paper
• Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice.

  2007cites this paper
• Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections

  2006cites this paper
• CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes

  2006cites this paper
• Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice.

  2006cites this paper
• Adjuvant Effect of the Propionibacterium acnes and Its Purified Soluble Polysaccharide on the Immunization with Plasmidial DNA Containing a Trypanosoma cruzi Gene

  2006cites this paper
• Anatomical Route of Invasion and Protective Mucosal Immunity in Trypanosoma cruzi Conjunctival Infection

  2006influential citation
• The non-palindromic adaptor-PCR method for the identification of the T-cell receptor genes of an interferon-gamma-secreting T-cell hybridomaspecific for trans-sialidase, an immunodominant Trypanosoma cruzi antigen.

  2006cites this paper
• Long-Term Protective Immunity Induced Against Trypanosoma cruzi Infection After Vaccination with Recombinant Adenoviruses Encoding Amastigote Surface Protein-2 and Trans-Sialidase

  2006cites this paper
• Type 1 Immunity Provides Both Optimal Mucosal and Systemic Protection against a Mucosally Invasive, Intracellular Pathogen

  2005cites this paper
• Based on Amastigote Surface Protein 2 Immunization with Recombinant Proteins Susceptible Mouse Strain after Infection in a Highly Trypanosoma cruzi-T-Cell-Dependent Control of + CD 8

  2005cites this paper
• Antigen-Specific T Cells Maintain an Effector Memory Phenotype during Persistent Trypanosoma cruzi Infection 1

  2005cites this paper
• The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

  2005cites this paper
• This information is current as Infection Trypanosoma cruzi Memory Phenotype during Persistent Antigen-Specific T Cells Maintain an Effector

  2005cites this paper
• Antigen-Specific T Cells Maintain an Effector Memory Phenotype during Persistent Trypanosoma cruzi Infection1

  2005cites this paper
• CD8+-T-Cell-Dependent Control of Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain after Immunization with Recombinant Proteins Based on Amastigote Surface Protein 2

  2005cites this paper
• Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.

  2004cites this paper
• DNA vaccines and their application against parasites--promise, limitations and potential solutions.

  2004cites this paper
• Protective Immunity Against Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain After Vaccination with Genes Encoding the Amastigote Surface Protein-2 and Trans-Sialidase

  2004cites this paper
• Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection

  2004cites this paper
• Immunization with cDNA Expressed by Amastigotes of Trypanosoma cruzi Elicits Protective Immune Response against Experimental Infection

  2003cites this paper
• Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.

  2003cites this paper
• Humoral and Cellular Immune Responses to Trypanosoma cruzi-Derived Paraflagellar Rod Proteins in Patients with Chagas' Disease

  2003cites this paper
• A DNA‐priming protein‐boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain

  2003cites this paper
• Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2beta protein in HLA-transgenic mice and patients.

  2003cites this paper
• Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines.

  2003cites this paper
• PDNF, a human parasite-derived mimic of neurotrophic factors, prevents caspase activation, free radical formation, and death of dopaminergic cells exposed to the Parkinsonism-inducing neurotoxin MPP+.

  2003cites this paper
• Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection.

  2003cites this paper
• Coadministration of an Interleukin-12 Gene and a Trypanosoma cruzi Gene Improves Vaccine Efficacy

  2002cites this paper
• Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection

  2002influential citation
• Identification and assessment of genetic vaccine candidates from Trypanosoma cruzi

  2002cites this paper
• Infection Trypanosoma cruzi in Responses and Decreases Disease Severity Antigen-Specific Protective Immune Genetic Immunization Elicits

  2002cites this paper
• Cruzipain Induces Both Mucosal and Systemic Protection against Trypanosoma cruzi in Mice

  2002cites this paper
• Endogenous Interleukin-4 Downregulates the Type 1 CD4 T Cell-Mediated Immune Response Induced by Intramuscular DNA Immunization

  2002influential citation
• Immune responses to gp 82 provide protection against mucosal Trypanosoma cruzi infection

  year unknowncites this paper